Oppenheimer (NYSE:OPY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Monday. Oppenheimer Trading ...
ScreenRant on MSN11d
Christopher Nolan's Next Movie Is Already Surpassing Oppenheimer In 1 Big Way That Didn't Seem Like It Was PossibleChristopher Nolan’s next project is an adaptation of The Odyssey, and though Oppenheimer is his biggest project to date, his ...
Tesla (NASDAQ:TSLA) shares rose 2.5% today, but the stock remains down ~17% year-to-date, suggesting the post-election ...
Investing.com -- Oppenheimer analysts warned that Tesla (NASDAQ: TSLA) faces rising risks as competition in both electric and ...
Oppenheimer downgraded shares of Playa Hotels & Resorts (NASDAQ:PLYA – Free Report) from an outperform rating to a market perform rating in a report published on Tuesday, MarketBeat reports. Other ...
Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...
The arrival of a wooden ancient trireme in Peloponnese, signals that filming of Christopher Nolan's epic "The Odyssey," begins in Greece.
While some clarity has lately emerged, with a handful of big wins for Sean Baker’s “Anora,” it seems likely to be a nail ...
About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback